MOUNTAIN VIEW, Calif., May 6, 2011 /PRNewswire/ — Alexza
Pharmaceuticals, Inc. (Nasdaq:
ALXA) today announced that company Senior Vice President and
Chief Financial Officer, August J. Moretti will present during the
MDB Bright Lights Conference 2011. The Alexza presentation
will be on Tuesday, May 10, 2011 at 10:00 a.m. Eastern Time.
The presentation will be webcast live from New York, NY.
To access the presentation via the Web, please go to the
Investor Relations tab at www.alexza.com or at http://www.wsw.com/webcast/mdb2/alxa/.
A replay of the webcast will be made available approximately
24 hours after the live presentation and the replay will be
archived for 90 days.
Additional information about the MDB Bright Lights Conference
2011 may be found at: http://www.mdb.com/2011-bright-lights-conference.html.
About Alexza Pharmaceuticals, Inc.
Alexza is a pharmaceutical company focused on the research,
development and commercialization of novel, proprietary products
for the acute treatment of central nervous system conditions.
Alexza’s technology, the Staccato® system, vaporizes
unformulated drug to form a condensation aerosol that, when
inhaled, allows for rapid systemic drug delivery through deep lung
inhalation. The drug is quickly absorbed through the lungs
into the bloodstream, providing speed of therapeutic onset that is
comparable to intravenous administration, but with greater ease,
patient comfort and convenience. (Click
here to see an animation of how the Staccato system
works.)
AZ-004 (Staccato loxapine) is Alexza’s lead program,
which is being develo
‘/>”/>
